Prosecution Insights
Last updated: July 17, 2026
Application No. 18/712,379

Medical Device Assembly

Non-Final OA §102§103
Filed
May 22, 2024
Priority
Nov 30, 2021 — provisional 63/284,271 +1 more
Examiner
DEAK, LESLIE R
Art Unit
3799
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Hollister Incorporated
OA Round
1 (Non-Final)
75%
Grant Probability
Favorable
1-2
OA Rounds
1y 1m
Est. Remaining
93%
With Interview

Examiner Intelligence

Grants 75% — above average
75%
Career Allowance Rate
710 granted / 943 resolved
+5.3% vs TC avg
Strong +18% interview lift
Without
With
+17.6%
Interview Lift
resolved cases with interview
Typical timeline
3y 3m
Avg Prosecution
34 currently pending
Career history
982
Total Applications
across all art units

Statute-Specific Performance

§101
0.8%
-39.2% vs TC avg
§103
72.3%
+32.3% vs TC avg
§102
7.0%
-33.0% vs TC avg
§112
0.9%
-39.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 943 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Claims 10-12 withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 17 June 2026. Claims 1-9 and 13-20 are examined herein on the merits. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claims 1, 2, 4, 7, 9, 13-17 and 19 are rejected under 35 U.S.C. 102(a)(1) and (a)(2) as being anticipated by WO 2018/156589 to McMenamin et al. In the specification and figures, McMenamin discloses the apparatus as claimed by Applicant. With regard to claims 1, 9, 13-16, 19, McMenamin discloses a medical device assembly comprising a case 1 with a generally cylindrical or rectangular hollow PNG media_image1.png 766 268 media_image1.png Greyscale tubular body 26 a with a closed first end 28 and an open collar end 36 with a hinged 42 cap 14 and a varying outer diameter (see FIG 1 and accompanying text). The interior surface comprises a chamber with ribs 19 and 20, as well as a removable hydrophilic catheter 22 with a funnel 24, drainage member and a tube (see FIGS 7, 12, and accompanying text, ¶00101, 00116). Because the catheter 22 with its drainage slot is within the case, it is in fluid communication with the area between the ribs. McMenamin further discloses that the apparatus may comprise a hydration liner 16, which carries hydrating liquid such as water (see ¶00100, 00116). With regard to claims 2, 4, 7, McMenamin discloses that the case insert may have a radially extending foot that engages a flange of the drainage funnel insert (see ¶0019). With regard to claim 17, McMenamin discloses that the case may flare outwardly (see ¶00170). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 3, 5, 6, 18, and 20 are rejected under 35 U.S.C. 103 as being unpatentable over 2018156589 to McMenamin et al. In the specification and figures, McMenamin teaches the apparatus substantially as claimed by Applicant (see rejections above). With regard to claim 3, McMenamin illustrates only a single slot on catheter 22. However, It has been held that the mere duplication of the parts of an apparatus found in the prior art is not patentably significant unless a new and unexpected result is produced. See MPEP § 2144.04 (VI)(B). In the instant case, providing multiple drainage slots would not produce an unexpected result. With regard to claim 5, McMenamin discloses a plug, which Applicant discloses is equivalent to the instantly claimed grommet, teaching the limitations of the claims (see Specification at ¶0037). With regard to claims 6 and 20, McMenamin discloses that the interior of the case comprises threads, flanges, lips, groves, seals, and the like are hidden under both one of the sleeve and the cap to accommodate the catheter and the various other components within the case, suggesting the limitations of the claim. With regard to claim 18, McMenamin discloses that ribs 19 and 21 extend from the bottom of the neck of the interior of the case to the top end of the collar (see ¶00107), teaching that the ribs taper towards an interior surface as the ribs extend in a proximal direction. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to LESLIE R DEAK whose telephone number is (571)272-4943. The examiner can normally be reached Monday-Friday, 9am to 5:30pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Sarah Al-Hashimi can be reached at 571-272-7159. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /LESLIE R DEAK/Primary Examiner, Art Unit 3799 30 June 2026
Read full office action

Prosecution Timeline

May 22, 2024
Application Filed
Jul 02, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12678550
NEW STANDARDIZATIONS & MEDICAL DEVICES FOR THE PREPARATION OF PLATELET RICH PLASMA (PRP) OR BONE MARROW CONCENTRATE (BMC) ALONE OR IN COMBINATION WITH HYALURONIC ACID
5y 0m to grant Granted Jul 14, 2026
Patent 12678328
INTRAOCULAR SHUNTS WITH LOW-PROFILE ACTUATION ELEMENTS AND ASSOCIATED SYSTEMS AND METHODS
3y 4m to grant Granted Jul 14, 2026
Patent 12667488
SHUNTING SYSTEMS WITH ROTATION-BASED FLOW CONTROL ASSEMBLIES, AND ASSOCIATED SYSTEMS AND METHODS
3y 2m to grant Granted Jun 30, 2026
Patent 12661263
EYE SHUNT SYSTEM AND METHODS
3y 6m to grant Granted Jun 23, 2026
Patent 12661264
STENT IMPLANT FOR TREATING GLAUCOMA BY MEANS OF INTRAOCULAR FLUID DRAINAGE FROM THE ANTERIOR CHAMBER
3y 3m to grant Granted Jun 23, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
75%
Grant Probability
93%
With Interview (+17.6%)
3y 3m (~1y 1m remaining)
Median Time to Grant
Low
PTA Risk
Based on 943 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month